Serological response to SARS-CoV-2 vaccination in multiple sclerosis patients treated with fingolimod or ocrelizumab: an initial real-life experience

por S., Guerrieri, S., Lazzarin, C., Zanetta, A., Nozzolillo, M., Filippi, L., Moiola
Publicado 2021